Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colorectal Neoplasms × mirdametinib × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

KRAS Mutant Non-Small Cell Lung Cancer 1 Colorectal Neoplasms 1

Interventions

Fluorouracil 65 pembrolizumab 56 Bevacizumab 54 Oxaliplatin 53 Leucovorin 52 Cetuximab 52 Irinotecan 51 Capecitabine 28 Nivolumab 19 Gemcitabine 17 Cisplatin 17 Folfox protocol 16 IFL protocol 15 Cyclophosphamide 15 Carboplatin 15 atezolizumab 14 Specimen Handling 14 Paclitaxel 14 Magnetic Resonance Spectroscopy 14 Biopsy 14 trifluridine tipiracil drug combination 11 Pemetrexed 10 spartalizumab 9 regorafenib 9 trametinib 8 dehydroftorafur 8 130-nm albumin-bound paclitaxel 8 fludarabine 7 durvalumab 7 Trifluridine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02510001 2021-07-13

MErCuRIC1

University of Oxford

Phase 1 Completed

82 enrolled 36 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡